NEO

Companies
NASDAQ
NeoGenomics Inc.
Health Care
Price Chart
Overview

About NEO

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.

Market Cap
$1.7B
Volume
11.4M
Avg. Volume
10.5M
P/E Ratio
43.625
Dividend Yield
0.00%
Employees
1.7K

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
1.14
Moderate Correlation
Volatility
High (0.68)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for NEO.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, NEO shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$1.7B
Volume11.4M
P/E Ratio43.63
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 18, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how NEO fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025